Amanote Research
Register
Sign In
Correction: The Impact of Non-Drug-Related Toxicities on the Estimation of the Maximum Tolerated Dose in Phase I Trials
Clinical Cancer Research
- United States
doi 10.1158/1078-0432.ccr-12-3447
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
November 27, 2012
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
The Role of Age on Dose-Limiting Toxicities (DLTs) in Phase I Dose-Escalation Trials.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Dose Titration Algorithm Tuning (DTAT) Should Supersede ‘The’ Maximum Tolerated Dose (MTD) in Oncology Dose-Finding Trials
F1000Research
Genetics
Molecular Biology
Pharmacology
Biochemistry
Microbiology
Immunology
Medicine
Toxicology
Pharmaceutics
Dose Titration Algorithm Tuning (DTAT) Should Supersede ‘The’ Maximum Tolerated Dose (MTD) in Oncology Dose-Finding Trials
F1000Research
Genetics
Molecular Biology
Pharmacology
Biochemistry
Microbiology
Immunology
Medicine
Toxicology
Pharmaceutics
P1.01-94 Phase I Trial to Establish Maximum Tolerated Dose Safety and Pharmacokinetic Profile of Oral Paclitaxel
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Phase I Clinical Trial to Determine the Feasibility and Maximum Tolerated Dose of Panitumumab to Standard Gemcitabine-Based Chemoradiation in Locally Advanced Pancreatic Cancer
Clinical Cancer Research
Cancer Research
Oncology
Safety and Efficacy of the Maximum Tolerated Dose of Givinostat in Polycythemia Vera: A Two-Part Phase Ib/Ii Study
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Sequential Designs for Phase I Clinical Trials With Late-Onset Toxicities
Biometrics
Statistics
Genetics
Probability
Molecular Biology
Biochemistry
Applied Mathematics
Microbiology
Immunology
Biological Sciences
Medicine
Agricultural
An Application of Reinforced Urn Processes to Determining Maximum Tolerated Dose
Statistics and Probability Letters
Uncertainty
Statistics
Probability
Maximum Tolerated Dose Evaluation of the AMPA Modulator Org 26576 in Healthy Volunteers and Depressed Patients
Drugs in R and D
Pharmacology